Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GPT HealthcareNSE:GPTHEALTH -1.18%45 Cash Ratio is 0.00 as of Jun. 2026. GuruFocus rates NSE:GPTHEALTH with a GF Score™ of 45/100. The stock has 4 warning signs investors should review. Among 669 Healthcare Providers & Services companies, GPT Healthcare ranks better than 50.67% on this metric.
GPT Healthcare has a Cash Ratio of 0.00. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for GPT Healthcare's Cash Ratio or its related term are showing as below:
NSE:GPTHEALTH'
s Cash Ratio Range Over the Past 10 Years
Min: 0.08 Med: 0.26 Max: 0.59
Current: 0.59
During the past 6 years, GPT Healthcare's highest Cash Ratio was 0.59. The lowest was 0.08. And the median was 0.26.
NSE:GPTHEALTH's Cash Ratio is ranked better than 50.67% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 0.58
vs NSE:GPTHEALTH: 0.59
GPT Healthcare (NSE:GPTHEALTH) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
GPT Healthcare Cash Ratio Related Terms
GPT Healthcare Cash Ratio Historical Data
* Premium members only.
The historical data trend for GPT Healthcare's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:GPTHEALTH vs HCA, THC, EHC: Cash Ratio Comparison
For the Medical Care Facilities subindustry, GPT Healthcare's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GPT Healthcare Cash Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GPT Healthcare's Cash Ratio distribution charts can be found below:
* The bar in red indicates where GPT Healthcare's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GPT Healthcare (NSE:GPTHEALTH) has a Cash Ratio of 0.00 as of Jun. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on GPT Healthcare and its competitors. Over the past decade, GPT Healthcare's Cash Ratio has ranged from 0.08 to 0.59. According to the industry distribution chart, GPT Healthcare ranks #330 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 49.3%.
Is GPT Healthcare's Cash Ratio too high?
GPT Healthcare's current Cash Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.08 to a high of 0.59. Based on the distribution chart, GPT Healthcare ranks #330 out of 669 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, GPT Healthcare has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does GPT Healthcare's Cash Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, GPT Healthcare ranks #330 out of 669 companies for Cash Ratio. This puts GPT Healthcare in the upper half of its industry. The industry median Cash Ratio is 0.58. Historically, GPT Healthcare's own Cash Ratio has ranged from 0.08 to 0.59 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Healthcare Providers & Services company?
The median Cash Ratio among Healthcare Providers & Services companies is 0.58, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on GPT Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Cash Ratio is 0.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GPT Healthcare's current Cash Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GPT Healthcare stock overvalued right now?
GPT Healthcare (NSE:GPTHEALTH) has a current Cash Ratio of 0.00. The current Cash Ratio is 0.00. GPT Healthcare's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For GPT Healthcare (NSE:GPTHEALTH), the current Cash Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GPT Healthcare Ltd is engaged in the healthcare sector. It operates a chain of mid-sized full-service hospitals under the ILS brand. It provides integrated healthcare services, with a focus on secondary and tertiary care and operates four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of approximately 561 beds. It offers a comprehensive range of healthcare services across over 35 specialities and super specialities, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology.
45GF Score
Get the complete analysis for NSE:GPTHEALTH
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GPTHEALTH has been successfully added to your 
